Etoricoxib tolerability in patients with hypersensitivity to nonsteroidal anti-inflammatory drugs

International Archives of Allergy and Immunology

Volumn 143, Issue 2, 2007, Pages 103-108

  Viola, Marinella ^a   Quaratino, Donato ^b   Gaeta, Francesco ^a   Caruso, Cristiano ^a   Valluzzi, Rocco ^a   Romano, Antonino ^a,c,d  

^a CATHOLIC UNIVERSITY   (Italy)

^b LABORATORIO DI PATOLOGIA VASCOLARE   (Italy)

^c OASI RESEARCH INSTITUTE IRCCS   (Italy)

^d Unita di Allergologia   (Italy)

Author keywords

Etoricoxib; Hypersensitivity; Nonsteroidal anti inflammatory drugs; Oral challenge test; Pyrazolones; Skin test

Indexed keywords

ACETYLSALICYLIC ACID; ADRENALIN; CHLORPHENIRAMINE; ETORICOXIB; KETOPROFEN; KETOROLAC; METHYLPREDNISOLONE; NIMESULIDE; NONSTEROID ANTIINFLAMMATORY AGENT; NORAMIDOPYRINE; PARACETAMOL; PROPYPHENAZONE; TAUXIB; UNCLASSIFIED DRUG;

ADULT; AGED; ANAPHYLAXIS; ANGIONEUROTIC EDEMA; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG DOSE INCREASE; DRUG HYPERSENSITIVITY; DRUG TOLERABILITY; DYSPNEA; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; IMMUNOLOGICAL PROCEDURES; MALE; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE; RHINITIS; SIDE EFFECT; SKIN DISEASE; SKIN MANIFESTATION; SKIN TEST; URTICARIA;

ADULT; AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CYCLOOXYGENASE INHIBITORS; FEMALE; HUMANS; HYPERSENSITIVITY, IMMEDIATE; MALE; MIDDLE AGED; PYRIDINES; SKIN TESTS; SULFONES;

EID: 34248336545     PISSN: 10182438     EISSN: None     Source Type: Journal    
DOI: 10.1159/000098658     Document Type: Article

References (25)

1. Mastalerz L, Setkowicz M, Sanak M, Szczeklik A: Hypersensitivity to aspirin: common eicosanoid alterations in urticaria and asthma. J Allergy Clin Immunol 2004;113:771-775.
2. Czerniawska-Mysik G, Szczeklik A: Idiosyncrasy to pyrazolone drugs. Allergy 1981;36:381-384.
3. Kowalski ML, Woszczek G, Bienkiewicz B, Mis M: Association of pyrazolone drug hypersensitivity with HLA-DQ and DR antigens. Clin Exp Allergy 1998;28:1153-1158.
4. Himly M, Jahn-Schmid B, Pittertschatscher K, Bohle B, Grubmayr K, Ferreira F, et al: IgE-mediated immediate-type hypersensitivity to the pyrazolone drug propyphenazone. J Allergy Clin Immunol 2003;111:882-888.
5. Szczeklik A, Stevenson DD: Aspirin-induced asthma: advances in pathogenesis, diagnosis, and management. J Allergy Clin Immunol 2003;111:913-921.
6. Szczeklik A, Sanak M, Nizankowska-Mogilnicka E, Kielbasa B: Aspirin intolerance and the cyclooxygenase-leukotriene pathways. Curr Opin Pulm Med 2004;10:51-56.
7. Quaratino D, Romano A, Papa G, Di Fonso M, Giuffreda F, Purello D'Ambrosio F, Venuti A: Long-term tolerability of nimesulide and acetaminophen in nonsteroidal anti-inflammatory drug-intolerant patients. Ann Allergy Asthma Immunol 1997;79:47-50.
8. Quaratino D, Romano A, Di Fonso M, Papa G, Perrone MR, Purello D'Ambrosio F, Venuti A: Tolerability of meloxicam in patients with histories of adverse reactions to nonsteroidal anti-inflammatory drugs. Ann Allergy Asthma Immunol 2000;84:613-617.
9. Szczeklik A, Nizankowska E, Bochenek G, Nagraba K, Mejza F, Swierczynska M: Safety of a specific COX-2 inhibitor in aspirin-induced asthma. Clin Exp Allergy 2001;31:219-225.
10. Stevenson DD, Simon RA: Lack of cross-reactivity between rofecoxib and aspirin in aspirin-sensitive patients with asthma. J Allergy Clin Immunol 2001;108:47-51.
11. Perrone MR, Artesani MC, Viola M, Gaeta F, Caringi M, Quaratino D, Romano A: Tolerability of rofecoxib in patients with adverse reactions to nonsteroidal anti-inflammatory drugs: a study of 216 patients and literature review. Int Arch Allergy Immunol 2003;132:82-86.
12. Viola M, Quaratino D, Gaeta F, Caringi M, Valluzzi R, Caruso C, et al: Celecoxib tolerability in patients with hypersensitivity (mainly cutaneous reactions) to nonsteroidal anti-inflammatory drugs. Int Arch Allergy Immunol 2005;137:145-150.
13. Viola M, Quaratino D, Volpetti S, Gaeta F, Romano A: Parecoxib tolerability in patients with hypersensitivity to nonsteroidal anti-inflammatory drugs. J Allergy Clin Immunol 2006;117:1189-1191.
14. Sánchez-Borges M, Caballero-Fonseca F, Capriles-Hulett A: Safety of etoricoxib, a new cyclooxygenase 2 inhibitor, in patients with nonsteroidal anti-inflammatory drug-induced urticaria and angioedema. Ann Allergy Asthma Immunol 2005;95:154-158.
15. Riendeau D, Percival MD, Brideau C, Charleson S, Dube D, Ethier D, Falgueyret JP, Friesen RW, Gordon R, Greig G, Guay J, Mancini J, Ouellet M, Wong E, Xu L, Boyce S, Visco D, Girard Y, Prasit P, Zamboni R, Rodger IW, Gresser M, Ford-Hutchinson AW, Young RN, Chan CC: Etoricoxib (MK-0663): preclinical profile and comparison with other agents that selectively inhibit cyclooxygenase-2. J Pharmacol Exp Ther 2001;296:558-566.
16. Nettis E, Colanardi MC, Ferrannini A, Vacca A, Tursi A: Short-term tolerability of etoricoxib in patients with cutaneous hypersensitivity reactions to nonsteroidal anti-inflammatory drugs. Ann Allergy Asthma Immunol 2005;95:438-442.
17. Zembowicz A, Mastalerz L, Setkowicz M, Radziszewski W, Szczeklik A: Safety of cyclooxygenase 2 inhibitors and increased leukotriene synthesis in chronic idiopathic urticaria with sensitivity to nonsteroidal anti-inflammatory drugs. Arch Dermatol 2003;139:1577-1582.
18. Nizankowska E, Bestynska-Krypel A, Cmiel A, Szczeklik A: Oral and bronchial provocation tests with aspirin for diagnosis of aspirin-induced asthma. Eur Respir J 2000;15:863-869.
19. Stevenson DD, Sánchez-Borges M, Szczeklik A: Classification of allergic and pseudoallergic reactions to drugs that inhibit cyclooxygenase enzymes. Ann Allergy Asthma Immunol 2001;87:177-180.
20. Aberer W, Bircher A, Romano A, Blanca M, Campi P, Fernandez J, Brockow K, Pichler WJ, Demoly P; European Network for Drug Allergy (ENDA); EAACI interest group on drug hypersensitivity: Drug provocation testing in the diagnosis of drug hypersensitivity reactions: general considerations. Allergy 2003;58:854-863.
21. Nahar IK, Muqim AT, Al-Qhouti BI, Al-Herz AA, Shehab DK, Uppal SS, Khadadah ME: The use of etoricoxib in patients with bronchial asthma associated with aspirin sensitivity. Saudi Med J 2006;27:119-120.
22. Messaad D, Sahla H, Benahmed S, Godard P, Bousquet J, Demoly P: Drug provocation tests in patients with a history suggesting an immediate drug hypersensitivity reaction. Ann Intern Med 2004;140:1001-1006.
23. Lammintausta K, Kortekangas-Savolainen O: Oral challenge in patients with suspected cutaneous adverse drug reactions: findings in 784 patients during a 25-year-period. Acta Derm Venereol 2005;85:491-496.
24. Schubert B, Grosse Perdekamp MT, Pfeuffer P, Raith P, Brocker EB, Trautmann A: Nonsteroidal anti-inflammatory drug hypersensitivity: fable or reality? Eur J Dermatol 2005;15:164-167.
25. Morais-Almeida M, Marinho S, Rosa S, Gaspar A, Rosado-Pinto JE: Multiple drug intolerance including etoricoxib. Allergy 2006;61:144-145.